Clovis Oncology Inc

NASDAQ:CLVS   3:59:59 PM EDT
1.84
-0.08 (-4.17%)
Earnings Announcements

Clovis Oncology Announces Preliminary Financial Results For Q4 And Full Year 2021

Published: 01/10/2022 13:07 GMT
Clovis Oncology Inc (CLVS) - Clovis Oncology Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021.
Clovis Oncology Inc - Estimated $35.5m - $36.1m in Rubraca (rucaparib) Global Sales for Q4 2021 and $148.3m - $148.9m for FY 2021.
Revenue is expected to be $40.04 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $40.42 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.